Log In
BCIQ
Print this Print this
 

GX301

  Manage Alerts
Collapse Summary General Information
Company Mediolanum Farmaceutici S.p.A.
DescriptionTelomerase-based vaccine
Molecular Target
Mechanism of ActionVaccine
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationProstate cancer
Indication DetailsTreat prostate cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

12/10/2012

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today